
Andira Pharmaceuticals Achieves Remarkable Breast Cancer Tumor Regression with Lead Oncology Candidate XOXO4
Opportunity to invest in Canadian health science firm pioneering innovative treatments for breast cancer is now open globally to eligible investors. SAN FRANCISCO, OCTOBER 2023 – US Capital Global Securities LLC, an affiliate of US Capital Global, recently launched an investment opportunity of up to $5 million in Canadian health